INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO HAVE GENOTYPE 3, CIRRHOSIS, ARE INTERFERON-INELIGIBLE/INTOLERANT, OR HAVE FAILED PREVIOUS THERAPY
- Author
- eViralHepatitis Review
- Published
- Wed 21 Jan 2015
- Episode Link
- https://shows.acast.com/eviralhepatitisreview/episodes/5fa6e85d4a2a5c52d1e331d9
Special Edition 2014, Issue 1, Part 1.
Mark S. Sulkowski, MD from Johns Hopkins University School of Medicine in Baltimore interviews Dr. David Nelson from the University of Florida about patients who have genotype 3 or cirrhosis, are interferon-ineligible/intolerant, or have failed previous therapy.
The post INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO HAVE GENOTYPE 3, CIRRHOSIS, ARE INTERFERON-INELIGIBLE/INTOLERANT, OR HAVE FAILED PREVIOUS THERAPY appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
